Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oligomet-DK: Surgery + SBRT for M1 Prostate Cancer
NCT04086290Phase 2Recruiting
- Start
- Oct 2019
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa). Primary endpoint: Proportion of men with Grade >= 3 adverse events at 1 year. Started Oct 2019; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04086290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04086290.